Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-15

Clinical Trial Update: Ferric Derisomaltose (Iron Isomaltoside) Versus Iron Sucrose for Treatment of Iron Deficiency in Pregnancy [Phase 3]

View source ↗

Summary

Phase 3 trial comparing ferric derisomaltose with iron sucrose for treating iron deficiency anemia in pregnancy is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ferric derisomaltose (iron isomaltoside) (iron isomaltoside)
  • Iron sucrose (iron sucrose)

Snippet

Sponsor: Saskatchewan Health Authority - Regina Area | Conditions: Iron Deficiency Anaemia in Childbirth | Phase 3 | Status: RECRUITING